TF2 - Immunomedics
Immunomedics: Commercial Update (Immunomedics) - Jul 23, 2016 - Anticipated patent expiry in US, Europe and Japan in 2026 
Anticipated patent expiry • Oncology
http://www.immunomedics.com/partnering5-demo.shtml
 
Jul 23, 2016
 
 
9a10064d-4c87-45f5-b060-201080416ef3.jpg